Case number 2017-1604
Pozen, Inc. v. Actavis Laboratories FL, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Mar 5, 2018 | 82 | ORDER granting motion to terminate appeal [81] filed by Appellees Actavis Pharma, Inc., Actavis Laboratories FL, Inc. and Appellants Horizon Pharma, Inc., Pozen, Inc. and Horizon Pharma USA, Inc.; issuing mandate. By: Merits Panel (Per Curiam). Service as of this date by the Clerk of Court. [502656] [17-1604, 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616] [SJ] [Entered: 03/05/2018 04:15 PM] (2) |
| Mar 5, 2018 | 81 | MOTION of Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc., Pozen, Inc. and Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. to terminate appeal through dismissal. [Consent: unopposed]. Service: 03/05/2018 by email. [502609] [Dominick Conde] [Entered: 03/05/2018 03:22 PM] (8) |
| Feb 15, 2018 | 80 | CORRECTED Response to oral argument order from the Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc. and Pozen, Inc.. designating Dominick A. Conde as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [498167] [Dominick Conde] [Entered: 02/15/2018 03:41 PM] (0) |
| Feb 14, 2018 | 79 | Response to oral argument order from the Appellant Pozen, Inc.. designating Dominick A. Conde as arguing attorney. Designated time for argument: 12 minutes. Designated time for rebuttal: 3 minutes. Service of other counsel by Notice of Docket Activity from this entry. [497730] [Dominick Conde] [Entered: 02/14/2018 03:28 PM] (0) |
| Jan 24, 2018 | 78 | Response to oral argument order from the Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. designating Marc D. Haefner as arguing attorney. Designated time for argument: 15 minutes. Designated time for rebuttal: 0 minutes. Service of other counsel by Notice of Docket Activity from this entry. [492389] [Katherine Romano] [Entered: 01/24/2018 02:51 PM] (0) |
| Jan 22, 2018 | 77 | NOTICE OF CALENDARING. Panel: 1803H. Case scheduled Mar 07, 2018 10:00 a.m. at the United States Court of Appeals for the Federal Circuit (Howard T. Markey National Courts Building, 717 Madison Place, N.W. Washington, DC 20439), Courtroom 402. Response to oral argument order due: 02/15/2018. Arguing counsel is required to check-in with the Clerk's Office, 4th Floor, Room 401, between 8:30 a.m. and 9:30 a.m. on the day of argument. Please review the Oral Argument Order. [491396] [JAB] [Entered: 01/22/2018 12:37 PM] (0) |
| Nov 21, 2017 | 76 | Letter from Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. encl. Order of Dismissal and Stipulation of Dismissal entered in the Yosprala litigation. Service: 11/21/2017 by email. [477290] [Liza Walsh] [Entered: 11/21/2017 10:04 AM] (7) |
| Oct 6, 2017 | 75 | Entry of appearance for Marc D. Haefner as of counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 10/06/2017 by email. [466148] [Marc Haefner] [Entered: 10/06/2017 02:07 PM] (2) |
| Sep 25, 2017 | 74 | 6 paper copies of the Confidential Joint Appendix (Vols. I-III) [72] received from Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc. and Pozen, Inc. [463322] [CW] [Entered: 09/25/2017 03:33 PM] (0) |
| Sep 21, 2017 | 71 | ORDER filed. The motion to withdraw [70] is granted. The motion to extend time to file the appendix [67] is withdrawn. Service: 09/21/2017 by clerk. [462717] [LMS] [Entered: 09/21/2017 12:48 PM] (2) |
| Sep 19, 2017 | 70 | Letter from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. Withdraw Motion filed on 9/18/17 - Dkt 67. Service: 09/19/2017 by email. [462207] [Mazda Antia] [Entered: 09/19/2017 05:14 PM] (7) |
| Sep 18, 2017 | 73 | APPENDIX FILED for Horizon Pharma USA, Inc. and Horizon Pharma, Inc. [68]. Number of Pages: 1422. Service: 09/18/2017 by email. [462854] [FMS] [Entered: 09/21/2017 04:11 PM] (1422) |
| Sep 18, 2017 | 72 | CONFIDENTIAL JOINT APPENDIX FILED for Horizon Pharma USA, Inc., Horizon Pharma, Inc. and Pozen, Inc. [69]. Number of Pages: 1422. Service: 09/18/2017 by email. The paper copies of the brief should be received by the court on or before 09/28/2017. [462849] [FMS] [Entered: 09/21/2017 04:00 PM] (0) |
| Sep 18, 2017 | 69 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: CONFIDENTIAL JOINT APPENDIX Service: 09/18/2017 by email. [461885] [Mazda Antia] [Entered: 09/18/2017 06:57 PM] (0) |
| Sep 18, 2017 | 68 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: JOINT APPENDIX. Service: 09/18/2017 by email. [461883] [Mazda Antia] [Entered: 09/18/2017 06:54 PM] (1422) |
| Sep 18, 2017 | 67 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to extend the time to submit print copies of Joint Appendix until District Court resolves sealing issues to file the appendix. Any response is due within 10 days of service [Consent: unopposed]. Service: 09/18/2017 by email. [461882] [Mazda Antia] [Entered: 09/18/2017 06:50 PM] (7) |
| Sep 18, 2017 | 66 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 09/18/2017 by email. [461880] [Mazda Antia] [Entered: 09/18/2017 06:36 PM] (3) |
| Sep 18, 2017 | 65 | Certificate of Compliance with Fed. Cir. R. 11(d) (Trial Court) for Appellant Pozen, Inc.. Service: 09/18/2017 by email. [461802] [Dominick Conde] [Entered: 09/18/2017 03:12 PM] (3) |
| Aug 8, 2017 | 64 | 6 paper copies of the Confidential Opening Response Brief [53] received from Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. [452543] [JCP] [Entered: 08/09/2017 10:17 AM] (0) |
| Aug 4, 2017 | 63 | 6 paper copies of the Reply Brief [57] received from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. [451661] [FMS] [Entered: 08/04/2017 04:32 PM] (0) |
| Aug 4, 2017 | 62 | 6 paper copies of the Reply Brief [55] received from Appellant Pozen, Inc.. [451655] [FMS] [Entered: 08/04/2017 04:25 PM] (0) |
| Aug 4, 2017 | 61 | Statement of Compliance with Fed. Cir. R. 33 for Appellants Horizon Pharma USA, Inc., Horizon Pharma, Inc., Pozen, Inc. and Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 08/04/2017 by email. [451599] [Dominick Conde] [Entered: 08/04/2017 02:46 PM] (4) |
| Aug 3, 2017 | 60 | ORDER filed. The motion [44] is granted. The joint appendix is due September 18, 2017. Service: 08/03/2017 by clerk. [451339] [LMS] [Entered: 08/03/2017 04:06 PM] (2) |
| Aug 2, 2017 | 59 | 6 paper copies of the Opening Brief [49] received from Appellant Pozen, Inc.. [451032] [FMS] [Entered: 08/02/2017 04:27 PM] (0) |
| Aug 2, 2017 | 58 | 6 paper copies of the Opening Brief [51] received from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. [451031] [FMS] [Entered: 08/02/2017 04:26 PM] (0) |
| Jul 31, 2017 | 54 | BRIEF FILED for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. [41]. Number of Pages: 56. Service: 07/05/2017 by email. [450768] [FMS] [Entered: 08/01/2017 05:00 PM] (71) |
| Jul 31, 2017 | 53 | CONFIDENTIAL BRIEF FILED for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. [42]. Number of Pages: 56. Service: 07/05/2017 by email. The paper copies of the brief should be received by the court on or before 08/08/2017. [450767] [FMS] [Entered: 08/01/2017 04:58 PM] (0) |
| Jul 31, 2017 | 52 | CORRECTED BRIEF FILED for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. [37]. Number of Pages: 56. Service: 06/30/2017 by email. [450762] [FMS] [Entered: 08/01/2017 04:44 PM] (100) |
| Jul 31, 2017 | 51 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. [39]. Number of Pages: 56. Service: 06/30/2017 by email. The paper copies of the brief should be received by the court on or before 08/08/2017. [450760] [FMS] [Entered: 08/01/2017 04:38 PM] (0) |
| Jul 31, 2017 | 50 | CORRECTED BRIEF FILED for Appellant Pozen, Inc. [40]. Number of Pages: 65. Service: 06/30/2016 by email. [450749] [FMS] [Entered: 08/01/2017 04:15 PM] (107) |
| Jul 31, 2017 | 49 | CORRECTED CONFIDENTIAL BRIEF FILED for Appellant Pozen, Inc. [35]. Number of Pages: 65. Service: 06/30/2017 by email. The paper copies of the brief should be received by the court on or before 08/08/2017. [450743] [FMS] [Entered: 08/01/2017 04:06 PM] (0) |
| Jul 31, 2017 | 48 | ORDER filed. The motions [36] [38] [43] are granted. The briefs are accepted for filing. A copy of this order and the motions papers will be transmitted to the merits panel assigned to these appeals.; - FOR CALENDAR. Service: 07/31/2017 by clerk. [450429] [LMS] [Entered: 07/31/2017 03:36 PM] (3) |
| Jul 28, 2017 | 57 | REPLY BRIEF FILED for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. [47]. Number of Pages: 29. Service: 07/28/2017 by email. [450868] [FMS] [Entered: 08/02/2017 10:51 AM] (38) |
| Jul 28, 2017 | 56 | CORRECTED ENTRY: REPLY BRIEF FILED for Appellant Pozen, Inc. [46]. Number of Pages: 29. Service: 07/28/2017 by email. [450843] --[Edited 08/02/2017 by clerk - Reason: to correct document link] [FMS] [Entered: 08/02/2017 10:06 AM] (40) |
| Jul 28, 2017 | 55 | CONFIDENTIAL REPLY BRIEF FILED for Appellant Pozen, Inc. [45]. Number of Pages: 29. Service: 07/28/2017 by email. The paper copies of the brief should be received by the court on or before 08/09/2017. [450830] [FMS] [Entered: 08/02/2017 09:48 AM] (0) |
| Jul 28, 2017 | 47 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: REPLY BRIEF. Service: 07/28/2017 by email. [450211] [Mazda Antia] [Entered: 07/28/2017 06:02 PM] (38) |
| Jul 28, 2017 | 46 | TENDERED from Appellant Pozen, Inc.. Title: REPLY BRIEF. Service: 07/28/2017 by email. [450118] [Dominick Conde] [Entered: 07/28/2017 03:18 PM] (40) |
| Jul 28, 2017 | 45 | TENDERED from Appellant Pozen, Inc.. Title: CONFIDENTIAL REPLY BRIEF Service: 07/28/2017 by email. [450116] [Dominick Conde] [Entered: 07/28/2017 03:17 PM] (0) |
| Jul 27, 2017 | 44 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to extend the time to 09/18/2017 to file the appendix. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/27/2017 by email. [449851] [Mazda Antia] [Entered: 07/27/2017 07:11 PM] (9) |
| Jul 5, 2017 | 42 | TENDERED from Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Title: CONFIDENTIAL RESPONSE BRIEF Service: 07/05/2017 by email. [444274] [Liza Walsh] [Entered: 07/05/2017 04:06 PM] (0) |
| Jul 5, 2017 | 41 | TENDERED from Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Title: RESPONSE BRIEF. Service: 07/05/2017 by email. [444271] [Liza Walsh] [Entered: 07/05/2017 04:00 PM] (71) |
| Jul 5, 2017 | 43 | MOTION of Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 07/05/2017 by email. [444275] [Liza Walsh] [Entered: 07/05/2017 04:12 PM] (10) |
| Jun 30, 2017 | 40 | TENDERED from Appellant Pozen, Inc.. Title: CORRECTED OPENING BRIEF. Service: 06/30/2017 by email. [443692] [Dominick Conde] [Entered: 06/30/2017 06:30 PM] (107) |
| Jun 30, 2017 | 39 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 06/30/2017 by email. [443691] [Mazda Antia] [Entered: 06/30/2017 06:29 PM] (0) |
| Jun 30, 2017 | 38 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/30/2017 by email. [443690] [Mazda Antia] [Entered: 06/30/2017 06:27 PM] (63) |
| Jun 30, 2017 | 37 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: CORRECTED OPENING BRIEF. Service: 06/30/2017 by email. [443689] [Mazda Antia] [Entered: 06/30/2017 06:24 PM] (100) |
| Jun 30, 2017 | 36 | MOTION of Appellant Pozen, Inc. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 06/30/2017 by email. [443686] [Dominick Conde] [Entered: 06/30/2017 06:15 PM] (75) |
| Jun 30, 2017 | 35 | TENDERED from Appellant Pozen, Inc.. Title: CORRECTED CONFIDENTIAL OPENING BRIEF Service: 06/30/2017 by email. [443683] [Dominick Conde] [Entered: 06/30/2017 06:07 PM] (0) |
| Jun 29, 2017 | 34 | Entry of appearance for Katherine M. Romano as of counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 06/29/2017 by email. [443095] [Katherine Romano] [Entered: 06/29/2017 11:51 AM] (2) |
| Jun 20, 2017 | 33 | ORDER filed. The motions to waive confidentiality requirements [30] [29] are denied without prejudice to the appellants filing corrected briefs or new motions with a corrected brief to the extent provided herein within 10 days from the date of filing of this order. Service: 06/20/2017 by clerk. [440714] [NL] [Entered: 06/20/2017 10:51 AM] (3) |
| May 26, 2017 | 32 | CLERK'S OFFICE QUALITY CONTROL MESSAGE: re: motion to waive confidentiality requirements Docket No. [30], motion to waive confidentiality requirements Docket No. [29], ERROR: The motions were filed using the incorrect relief. The parties are seeking to waive confidentiality requirements, not seal a document. CORRECTION: The court, as a courtesy, has corrected the relief being requested. There is no need to refile the motions. THIS MESSAGE IS FOR INFORMATIONAL PURPOSES ONLY. [434316] [JCA] [Entered: 05/26/2017 09:13 AM] (0) |
| May 25, 2017 | 31 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: OPENING BRIEF. Service: 05/25/2017 by email. [434291] [Mazda Antia] [Entered: 05/25/2017 08:29 PM] (0) |
| May 25, 2017 | 30 | MOTION of Appellant Pozen, Inc. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/25/2017 by email. [434289]--[Edited 05/26/2017 by clerk to reflect correct relief being requested] [Dominick Conde] [Entered: 05/25/2017 07:59 PM] (74) |
| May 25, 2017 | 29 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to waive confidentiality requirements. Any response is due within 10 days of service [Consent: unopposed]. Service: 05/25/2017 by email. [434284]--[Edited 05/26/2017 by clerk to reflect correct relief being requested] [Mazda Antia] [Entered: 05/25/2017 07:37 PM] (62) |
| May 25, 2017 | 28 | TENDERED from Appellant Pozen, Inc.. Title: CONFIDENTIAL OPENING BRIEF Service: 05/25/2017 by email. [434283] [Dominick Conde] [Entered: 05/25/2017 07:36 PM] (0) |
| May 25, 2017 | 27 | TENDERED from Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Title: CONFIDENTIAL OPENING BRIEF Service: 05/25/2017 by email. [434282] [Mazda Antia] [Entered: 05/25/2017 07:35 PM] (0) |
| May 25, 2017 | 26 | TENDERED from Appellant Pozen, Inc.. Title: OPENING BRIEF. Service: 05/25/2017 by email. [434281] [Dominick Conde] [Entered: 05/25/2017 07:18 PM] (0) |
| May 19, 2017 | 25 | Entry of appearance for Joshua D. Calabro as of counsel for Appellant Pozen, Inc.. Service: 05/19/2017 by email. [432905] [Joshua Calabro] [Entered: 05/19/2017 03:15 PM] (2) |
| Mar 23, 2017 | 24 | ORDER filed. The motion [21] is granted. The appellants’ opening briefs are due no later than May 25, 2017; the appellees’ response brief is due no later than July 5, 2017; and the appellants’ reply briefs are due no later than July 28, 2017. Service: 03/23/2017 by clerk. [418435] [LMS] [Entered: 03/23/2017 02:53 PM] (2) |
| Mar 23, 2017 | 23 | Amended Certificate of Interest for the Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 03/23/2017 by email. [418391] [Liza Walsh] [Entered: 03/23/2017 02:10 PM] (4) |
| Mar 21, 2017 | 22 | REMINDER: All counsel of record are reminded of their responsibility per Fed. Cir. R. 47.4(a)and Fed. Cir. R. 47.3 to promptly submit an amended Certificate of Interest (COI) and/or Entry of Appearance (EOA) as information changes during the pendency of the appeal. Failure to comply with these Rules may delay the timely processing of your case or result in adverse action. [417220] [JCA] [Entered: 03/21/2017 08:38 AM] (0) |
| Mar 16, 2017 | 21 | MOTION of Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. to set briefing schedule. Any response is due within 10 days of service [Consent: unopposed]. Service: 03/16/2017 by email. [416312] [Mazda Antia] [Entered: 03/16/2017 03:31 PM] (10) |
| Feb 28, 2017 | 20 | Corrected Entry of appearance for Gary E. Hood as of counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/28/2017 by email. [411179] [Gary Hood] [Entered: 02/28/2017 12:12 PM] (2) |
| Feb 28, 2017 | 19 | NOTICE OF DEFICIENCY: The attorney entry of appearance Document No. [17] filed by Appellees Actavis Pharma, Inc. and Actavis Laboratories FL, Inc. in 17-1604 is indicating more than one principal attorney for the party(s) and therefore cannot be accepted for filing at this time. Liza M. Walsh has already entered an appearance as lead counsel for the Actavis parties. You are being afforded the opportunity to correct the deficiency. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [411075] [JCA] [Entered: 02/28/2017 10:00 AM] (0) |
| Feb 27, 2017 | 18 | Entry of appearance for Mark T. Deming as of counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/27/2017 by email. [411011] [Mark Deming] [Entered: 02/27/2017 07:23 PM] (2) |
| Feb 27, 2017 | 17 | Entry of appearance for Gary E. Hood as of counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/27/2017 by email. [411005] [Gary Hood] [Entered: 02/27/2017 06:37 PM] (0) |
| Feb 23, 2017 | 16 | Corrected Docketing Statement for the Appellant Pozen, Inc.. Service: 02/23/2017 by email. [410255] [Dominick Conde] [Entered: 02/23/2017 05:38 PM] (4) |
| Feb 23, 2017 | 15 | NOTICE OF DEFICIENCY: The docketing statement Document No. [13] filed by Appellant Pozen, Inc. in 17-1604 is incomplete and therefore cannot be accepted for filing at this time. You are being afforded the opportunity to correct the deficiency. Page 1 of the Docketing Statement is illegible. At the discretion of the court, the corrected document may be accepted for filing if received before midnight (EST) on the date of this notice. [410174] [JCA] [Entered: 02/23/2017 03:54 PM] (0) |
| Feb 23, 2017 | 14 | Certificate of Interest for the Appellant Pozen, Inc.. Service: 02/23/2017 by email. [410156] [Dominick Conde] [Entered: 02/23/2017 03:40 PM] (2) |
| Feb 23, 2017 | 13 | Docketing Statement for the Appellant Pozen, Inc.. Service: 02/23/2017 by email. [410152] [Dominick Conde] [Entered: 02/23/2017 03:39 PM] (0) |
| Feb 23, 2017 | 12 | Entry of appearance for Ellen Scordino as of counsel for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 02/23/2017 by email. [410092] [Ellen Scordino] [Entered: 02/23/2017 02:13 PM] (2) |
| Feb 23, 2017 | 11 | Transcript Purchase Order Form for the Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc. indicating that a transcript is already on file. Service: 02/23/2017 by email. [410089] [Mazda Antia] [Entered: 02/23/2017 01:59 PM] (2) |
| Feb 23, 2017 | 10 | Certificate of Interest for the Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 02/23/2017 by email. [410088] [Mazda Antia] [Entered: 02/23/2017 01:59 PM] (2) |
| Feb 23, 2017 | 9 | Docketing Statement for the Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 02/23/2017 by email. [410087] [Mazda Antia] [Entered: 02/23/2017 01:58 PM] (4) |
| Feb 23, 2017 | 8 | Entry of appearance for Mazda K. Antia as principal counsel for Appellants Horizon Pharma USA, Inc. and Horizon Pharma, Inc.. Service: 02/23/2017 by email. [410085] [Mazda Antia] [Entered: 02/23/2017 01:57 PM] (2) |
| Feb 23, 2017 | 7 | Docketing Statement for the Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/23/2017 by email. [410011] [Liza Walsh] [Entered: 02/23/2017 12:12 PM] (4) |
| Feb 23, 2017 | 6 | Certificate of Interest for the Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/23/2017 by email. [410007] [Liza Walsh] [Entered: 02/23/2017 12:09 PM] (4) |
| Feb 23, 2017 | 5 | Entry of appearance for Liza M. Walsh as principal counsel for Appellees Actavis Laboratories FL, Inc. and Actavis Pharma, Inc.. Service: 02/23/2017 by email. [410004] [Liza Walsh] [Entered: 02/23/2017 12:07 PM] (2) |
| Feb 22, 2017 | 4 | Transcript Purchase Order Form for the Appellant Pozen, Inc. indicating that a transcript is already on file. Service: 02/22/2017 by email. [409819] [Dominick Conde] [Entered: 02/22/2017 06:34 PM] (2) |
| Feb 22, 2017 | 3 | Entry of appearance for Dominick A. Conde as principal counsel for Appellant Pozen, Inc.. Service: 02/22/2017 by email. [409816] [Dominick Conde] [Entered: 02/22/2017 06:29 PM] (2) |
| Feb 9, 2017 | 2 | Note to file: The following cases are associated:17-1604 Lead with 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616 Consolidated. FURTHER ENTRIES WILL BE ADDED TO THE LEAD APPEAL ONLY. [406143] [17-1604, 17-1605, 17-1606, 17-1607, 17-1608, 17-1610, 17-1611, 17-1612, 17-1613, 17-1614, 17-1615, 17-1616] [JCA] [Entered: 02/09/2017 03:45 PM] (0) |
| Feb 9, 2017 | 1 | Appeal docketed. Received: 02/09/2017. [406093]Entry of Appearance due 02/23/2017. Certificate of Interest is due on 02/23/2017. Docketing Statement due 02/23/2017. Appellant/Petitioner's brief is due 04/10/2017. [JCA] [Entered: 02/09/2017 02:51 PM] (30) |
